Mount Yale Investment Advisors LLC Sells 2,907 Shares of Avantor, Inc. (NYSE:AVTR)

Mount Yale Investment Advisors LLC cut its stake in Avantor, Inc. (NYSE:AVTR) by 21.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,343 shares of the company’s stock after selling 2,907 shares during the quarter. Mount Yale Investment Advisors LLC’s holdings in Avantor were worth $268,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in AVTR. Versant Capital Management Inc grew its position in Avantor by 2,003.6% in the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after purchasing an additional 1,102 shares during the period. Blue Trust Inc. grew its holdings in shares of Avantor by 1,830.3% in the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after acquiring an additional 1,391 shares during the period. UMB Bank n.a. purchased a new stake in Avantor during the third quarter valued at $49,000. GAMMA Investing LLC lifted its holdings in Avantor by 89.9% in the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after acquiring an additional 1,285 shares during the period. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH purchased a new position in Avantor in the first quarter worth about $93,000. 95.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Avantor

In other news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the sale, the chief accounting officer now directly owns 29,544 shares in the company, valued at $740,372.64. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.50% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on AVTR shares. Wells Fargo & Company assumed coverage on shares of Avantor in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $30.00 price objective on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $34.00 target price on shares of Avantor in a report on Thursday, September 26th. Stifel Nicolaus lifted their price target on shares of Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. UBS Group reduced their price objective on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, October 8th. Finally, Barclays lowered their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $27.79.

Avantor Stock Down 3.6 %

AVTR opened at $22.43 on Monday. The company has a market capitalization of $15.24 billion, a PE ratio of 57.51, a price-to-earnings-growth ratio of 2.93 and a beta of 1.33. The firm has a 50-day simple moving average of $25.49 and a two-hundred day simple moving average of $24.26. The company has a quick ratio of 1.05, a current ratio of 1.59 and a debt-to-equity ratio of 0.89. Avantor, Inc. has a 52 week low of $16.63 and a 52 week high of $28.00.

Avantor (NYSE:AVTR) last released its quarterly earnings results on Friday, October 25th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.01. The business had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.72 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. Analysts forecast that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.